Status:
COMPLETED
Blood Loss at the Time of First Trimester Surgical Abortion in Anticoagulated Women
Lead Sponsor:
University of Hawaii
Collaborating Sponsors:
Oregon Health and Science University
Conditions:
Blood Loss
Eligibility:
FEMALE
18-50 years
Brief Summary
The primary objective of this study is to compare blood loss resulting from surgical termination of pregnancy up to 12 weeks gestation between women who are anticoagulated to therapeutic levels and th...
Detailed Description
We intend to conduct a prospective cohort study at Oregon Health and Science University and the University of Hawaii. This study will not be blinded and subjects will not be randomized. Women will be ...
Eligibility Criteria
Inclusion
- Female seeking abortion services
- Less than or equal to 12 weeks gestation
- Age 18-50
- Willing and able to sign informed consent
- Use of Coumadin or LMW heparin (treatment group only)
Exclusion
- Unwilling or unable to sign informed consent
- Women taking daily aspirin or herbal therapies containing gingko biloba
- Women with a known history of a bleeding disorder such as von willebrand's disease
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00614432
Start Date
January 1 2008
End Date
April 1 2010
Last Update
July 18 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Hawaii
Honolulu, Hawaii, United States, 96822
2
Oregon Health and Science University
Portland, Oregon, United States, 97239